Myocardial perfusion imaging associated with 31% cost reduction -- clinical study.
This article was originally published in The Gray Sheet
MYOCARDIAL PERFUSION IMAGING ASSOCIATED WITH 31% COST SAVINGS according to results from the Economics of Noninvasive Diagnosis (END) study, presented Nov. 13 at the American Heart Association scientific sessions in New Orleans. Average three-year per-patient medical costs for patients who underwent stress MPI imaging prior to referral for catheterization (n=5,823) was $3,470, $1,571 lower than the average three-year $5,041 per-patient cost for patients who did not receive the cardiac blood flow screening technique (n=5,423).
You may also be interested in...
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.
A lower first dose boosted the vaccine’s efficacy result, but AstraZeneca has conceded that this has to be proven in a separate trial. In the meantime, the UK government has asked the regulator to assess the vaccine under a special health emergency provision.